ClinicalTrials.Veeva

Menu

Cardiac Resynchronization Therapy, Dyspnea and Exercise Tolerance in Patients With Congestive Heart Failure (CHF)

Q

Queen's University

Status and phase

Terminated
Phase 4

Conditions

Congestive Heart Failure

Treatments

Device: Active Cardiac Resynchronization Therapy (CRT)

Study type

Interventional

Funder types

Other

Identifiers

NCT00700700
DMED-1082-07

Details and patient eligibility

About

A new therapy for patients with advanced heart failure (HF) involves the implantation of a specialized pacemaker device (Cardiac Resynchronization Therapy, CRT) that attempts to restore the synchronized contraction of the ventricular chambers of the heart. In some people, CRT improves exertional breathlessness and allows them to exercise for longer periods. However, to date, the mechanisms by which CRT improves symptoms and exercise tolerance is unknown. This study will use in-depth cardiopulmonary exercise testing and pulmonary function testing to explore these mechanisms in greater detail.

Enrollment

2 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinically stable
  • being considered for implantation of biventricular pacemaker for CRT
  • LVEF <35%
  • QRS duration >120 msec
  • NYHA III-IV functional class
  • optimized pharmacologic management of CHF
  • no recent (<1 month) episodes of decompensated CHF

Exclusion criteria

  • inability to perform cycle ergometry or comply with testing
  • uncontrolled ischemic heart disease
  • coronary revascularization within 3 months of study entry
  • concurrent primary lung disease
  • current use of ambulatory oxygen
  • rhythm other than sinus
  • dependency on pacemaker therapy as a consequence of bradyarrhythmias
  • severe valvulopathy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

2 participants in 2 patient groups

CRT-ON/CRT-OFF
Active Comparator group
Description:
Group initially randomized to CRT-ON, then cross-over to CRT-OFF
Treatment:
Device: Active Cardiac Resynchronization Therapy (CRT)
CRT-OFF/CRT-ON
Active Comparator group
Description:
Group initially randomized to CRT-OFF, then cross-over to CRT-ON
Treatment:
Device: Active Cardiac Resynchronization Therapy (CRT)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems